Eleven Biotherapeutics (EBIO) Swings to Q3 Profit

November 14, 2016 7:11 AM EST
Get Alerts EBIO Hot Sheet
Trade EBIO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q3 EPS of $0.95, versus $0.50 reported last year. Revenue for the quarter came in at $28.7 million, versus $100 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment